Published in Infect Immun on October 25, 2010
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol (2012) 1.39
Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One (2011) 1.25
CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res (2014) 1.10
In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med (2013) 0.99
Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front Microbiol (2015) 0.97
Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection. Infect Immun (2013) 0.92
Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol (2014) 0.92
Study and use of the probiotic Lactobacillus reuteri in pigs: a review. J Anim Sci Biotechnol (2015) 0.88
Marked seasonal variation in the wild mouse gut microbiota. ISME J (2015) 0.82
Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype. Front Cell Infect Microbiol (2015) 0.80
Behavior of lactobacilli isolated from fermented slurry (ben-saalga) in gnotobiotic rats. PLoS One (2013) 0.80
Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri. Mucosal Immunol (2015) 0.80
Involvement of the mannose receptor and p38 mitogen-activated protein kinase signaling pathway of the microdomain of the integral membrane protein after enteropathogenic Escherichia coli infection. Infect Immun (2012) 0.79
Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome. BMC Res Notes (2014) 0.77
Gut Microbiome and Kidney Disease in Pediatrics: Does Connection Exist? Front Microbiol (2016) 0.75
Microbial lysate upregulates host oxytocin. Brain Behav Immun (2016) 0.75
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med (1988) 5.92
Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology (1999) 5.03
Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol (2005) 4.63
Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol (1999) 3.75
Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res (2005) 3.22
Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev (2008) 3.12
Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach--United States, September 2006. MMWR Morb Mortal Wkly Rep (2006) 2.97
Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics (2005) 2.64
An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med (1999) 2.56
The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol (2001) 2.44
Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol (2004) 1.97
Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr (1997) 1.80
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis (2008) 1.77
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J (1997) 1.71
Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol (2009) 1.62
Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine. Infect Immun (2009) 1.54
Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol (2007) 1.51
Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun (2004) 1.48
Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun (2008) 1.43
Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun (2008) 1.20
The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol (2004) 1.19
Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol (2002) 1.18
The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J Microbiol Methods (2008) 1.10
3-hydroxypropionaldehyde: applications and perspectives of biotechnological production. Appl Microbiol Biotechnol (2003) 1.09
Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine. Infect Immun (2006) 1.06
The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology (2010) 1.05
Emerging water-borne pathogens. Appl Microbiol Biotechnol (2003) 1.04
Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study. Environ Health (2005) 1.02
Haemolytic uraemic syndrome: an overview. Nephrology (Carlton) (2006) 1.01
Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Infect Dis (2010) 0.97
Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Int J Food Microbiol (2006) 0.93
Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains. Antonie Van Leeuwenhoek (2009) 0.92
Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro. Lett Appl Microbiol (2008) 0.89
Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl Environ Microbiol (2008) 0.88
Escherichia coli O157: what every internist and gastroenterologist should know. Curr Gastroenterol Rep (2009) 0.86
Therapeutic effect of anti-TNF-alpha antibody and levofloxacin (LVFX) in a mouse model of enterohemorrhagic Escherichia coli O157 infection. Comp Immunol Microbiol Infect Dis (2001) 0.78
Identification of catabolite repression as a physiological regulator of biofilm formation by Bacillus subtilis by use of DNA microarrays. J Bacteriol (2003) 2.21
Identification of AbrB-regulated genes involved in biofilm formation by Bacillus subtilis. Mol Microbiol (2004) 2.09
Incorporating genomics and bioinformatics across the life sciences curriculum. PLoS Biol (2010) 1.89
Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci U S A (2010) 1.59
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One (2012) 1.50
The essential GTPase RbgA (YlqF) is required for 50S ribosome assembly in Bacillus subtilis. Mol Microbiol (2006) 1.47
Multiple GTPases participate in the assembly of the large ribosomal subunit in Bacillus subtilis. J Bacteriol (2006) 1.41
Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730. Appl Environ Microbiol (2008) 1.23
The essential GTPase YqeH is required for proper ribosome assembly in Bacillus subtilis. J Bacteriol (2007) 1.21
High efficiency recombineering in lactic acid bacteria. Nucleic Acids Res (2012) 1.21
The early response to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a putative cell wall-altering esterase. Appl Environ Microbiol (2007) 1.15
Structural maintenance of chromosomes protein of Bacillus subtilis affects supercoiling in vivo. J Bacteriol (2002) 1.14
The lactococcal phages Tuc2009 and TP901-1 incorporate two alternate forms of their tail fiber into their virions for infection specialization. J Biol Chem (2013) 1.11
The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology (2010) 1.05
Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol (2013) 1.04
Exploring optimization parameters to increase ssDNA recombineering in Lactococcus lactis and Lactobacillus reuteri. Bioengineered (2012) 1.01
Biochemical characterization of ribosome assembly GTPase RbgA in Bacillus subtilis. J Biol Chem (2012) 0.95
Functional domains of the 50S subunit mature late in the assembly process. Nucleic Acids Res (2013) 0.94
Global transcriptional response of Lactobacillus reuteri to the sourdough environment. Syst Appl Microbiol (2008) 0.91
Flux analysis of the Lactobacillus reuteri propanediol-utilization pathway for production of 3-hydroxypropionaldehyde, 3-hydroxypropionic acid and 1,3-propanediol from glycerol. Microb Cell Fact (2014) 0.89
Interactions of an essential Bacillus subtilis GTPase, YsxC, with ribosomes. J Bacteriol (2007) 0.88
Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes (2011) 0.87
Complete genome sequence of Candidatus Ruthia magnifica. Stand Genomic Sci (2010) 0.86
Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14. Appl Environ Microbiol (2008) 0.85
Gene dosage-dependent negative regulatory role of β-arrestin-2 in polymicrobial infection-induced inflammation. Infect Immun (2013) 0.84
SOS induction in a subpopulation of structural maintenance of chromosome (Smc) mutant cells in Bacillus subtilis. J Bacteriol (2007) 0.84
Role of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro. Microbiology (2014) 0.84
Precision genome engineering in lactic acid bacteria. Microb Cell Fact (2014) 0.83
Mutational analysis of the ribosome assembly GTPase RbgA provides insight into ribosome interaction and ribosome-stimulated GTPase activation. Nucleic Acids Res (2013) 0.82
Glycerol supplementation enhances L. reuteri's protective effect against S. Typhimurium colonization in a 3-D model of colonic epithelium. PLoS One (2012) 0.81
Intrinsic tryptophan fluorescence as a probe of metal and alpha-ketoglutarate binding to TfdA, a mononuclear non-heme iron dioxygenase. J Inorg Biochem (2003) 0.79
The human microbiome and infectious diseases: beyond koch. Interdiscip Perspect Infect Dis (2009) 0.77
A practical synthesis of 5-lipoxygenase inhibitor MK-0633. J Org Chem (2010) 0.75